These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35223105)

  • 41. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depressive symptoms in individuals diagnosed with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in middle-aged and older Chinese individuals: Results from the China Health and Retirement Longitudinal Study.
    Zhang W; Cao G; Sun Y; Wu F; Wang Q; Xu T; Hu H; Xu K
    J Affect Disord; 2022 Jan; 296():660-666. PubMed ID: 34565588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
    Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
    Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.
    Ilo D; Raluy-Callado M; Graham-Clarke P; Sadasivan R; Birt J; Donaldson R; Zhu E; Kirby MG; Neasham D
    Int J Clin Pract; 2015 Aug; 69(8):853-62. PubMed ID: 26011100
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.
    Mirone V; Sessa A; Giuliano F; Berges R; Kirby M; Moncada I
    Int J Clin Pract; 2011 Sep; 65(9):1005-13. PubMed ID: 21718399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment Patterns and Patient Reported Outcomes in Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms.
    Park YH; Kim TH; Lee SW; Chung BH; Cho JS; Lee JY
    Low Urin Tract Symptoms; 2017 May; 9(2):75-81. PubMed ID: 28394492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake.
    Gass R
    BJU Int; 2002 Nov; 90(7):649-54. PubMed ID: 12410741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT; Rademaker A; Lloyd GL; Gann P
    J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and correlates of diabetes and its comorbidities in four Gulf Cooperation Council countries: evidence from the World Health Survey Plus.
    Morgan SA; Ali MM; Channon AA; Al-Sabahi S; Al Suwaidi H; Osman N; Al Salameen M; Khoja T
    J Epidemiol Community Health; 2019 Jul; 73(7):630-636. PubMed ID: 30894421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.
    Kokturk N; Polatli M; Oguzulgen IK; Saleemi S; Al Ghobain M; Khan J; Doble A; Tariq L; Aziz F; El Hasnaoui A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1377-1388. PubMed ID: 29731625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.
    Fourcade RO; Lacoin F; Rouprêt M; Slama A; Le Fur C; Michel E; Sitbon A; Cotté FE
    World J Urol; 2012 Jun; 30(3):419-26. PubMed ID: 21892656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status.
    Blanker MH; Groeneveld FP; Prins A; Bernsen RM; Bohnen AM; Bosch JL
    BJU Int; 2000 Apr; 85(6):665-71. PubMed ID: 10759662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.
    Meigs JB; Mohr B; Barry MJ; Collins MM; McKinlay JB
    J Clin Epidemiol; 2001 Sep; 54(9):935-44. PubMed ID: 11520654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body size throughout the life-course and incident benign prostatic hyperplasia-related outcomes and nocturia.
    Khan S; Wolin KY; Pakpahan R; Grubb RL; Colditz GA; Ragard L; Mabie J; Breyer BN; Andriole GL; Sutcliffe S
    BMC Urol; 2021 Mar; 21(1):47. PubMed ID: 33773592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males.
    Xiong Y; Zhang Y; Li X; Qin F; Yuan J
    Aging Male; 2020 Dec; 23(5):1432-1439. PubMed ID: 32583703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms.
    Norman RW; Nickel JC; Fish D; Pickett SN
    Br J Urol; 1994 Nov; 74(5):542-50. PubMed ID: 7530115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Screening of clinical benign prostatic hypertrophy in general practice: survey of 18,540 men].
    Flam T; Montauban V
    Prog Urol; 2003 Jun; 13(3):416-24. PubMed ID: 12940193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.